ConductScience.org, home

Paper7200547

[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].

von Heyden HW and 3 others. Klin Wochenschr, 1982. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]. Papers, record 7200547. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7200547

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
PubMed
Journal
Klin Wochenschr
PubMed
Year
1982
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2019-07-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1von Heyden HWH W
2Henkel HH
3Nagel GAG A
4Weinstock NN

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
PlatinumMajor topic
Adult
Carcinoma, Squamous Cell
Female
Head and Neck Neoplasms
Humans
Infusions, Parenteral
Kinetics
Lung Neoplasms
Lymphoma
Male
Middle Aged
Ovarian Neoplasms
Testicular Neoplasms

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1699184Distribution of cis-platin in blood.Chem Biol Interact1978https://conductscience.org/library/papers/699184PubMed
2455315Reduction of the renal toxicity of cis-dichlorodiammineplatinum(II) by probenecid.Cancer Treat Rep1979https://conductscience.org/library/papers/455315PubMed
3498151Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).Cancer Treat Rep1979https://conductscience.org/library/papers/498151PubMed
4688279Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.Cancer Treat Rep1978https://conductscience.org/library/papers/688279PubMed
57189692Quantitative changes in cis-dichlorodiammineplatinum(II) speciation in excreted urine with time after iv infusion in man: methods of analysis, preliminary studies, and clinical results.Cancer Treat Rep1980https://conductscience.org/library/papers/7189692PubMed
66161715Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6161715PubMed
7387221Mechanism of action of cis-dichlorodiammineplatinum(II).Cancer Treat Rep1979https://conductscience.org/library/papers/387221PubMed
8657154Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.Cancer Treat Rep1978https://conductscience.org/library/papers/657154PubMed
94515709Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).Cancer Res1973https://conductscience.org/library/papers/4515709PubMed
10121143[Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].Klin Wochenschr1979https://conductscience.org/library/papers/121143PubMed
11421230Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis.Cancer Treat Rep1979https://conductscience.org/library/papers/421230PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
2752507Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2752507

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7200547

GET https://conductscience.org/api/papers/v1/7200547/authors